Corning Life Sciences will be hosting a virtual 3D Cell Culture Summit, June 16-17, that will bring together industry leaders and innovators to share ideas and information, and to discuss the future of 3D applications including spheroid, organoid and tissue models 3D workflow optimisation, trends, and innovation.
Some of the topics covered include: Human Pluripotent Stem Cell-Derived Organoids for COVID-19 Disease Modelling and Drug Screening (June 16, 12:55 PM – 1:25 PM EDT); Tackling Brain Tumours with a New Organoid Model (June 16, 2:50 PM – 3:20 PM EDT); Panel Discussion: Organoids as Patient Avatars for Personalised Medicine (June 16, 1:55 PM – 2:40 PM EDT); Characterisation and Diagnostic Applications of Patient-derived Tumour Organoids (June 17, 12:45 PM – 1:15 PM EDT); Level Up: A Panel Discussion on 3 Dimensional Cultures in a High Throughput Environment (June 17, 1:15 PM – 1:45 PM EDT); and Pairing Comprehensive Genomics with Combination Drug Screening to Identify Mutation Specific Therapeutic Approaches (June 17, 1:45 PM – 2:15 PM EDT).
Discussion will span across a variety of well-known life science leaders, including presenters from the Hubrecht Organoid Technology (HUB), Columbia University Laboratory For Stem Cells And Tissue Engineering, Cancer Research Centre of Lyon, Weill Cornell Medicine, Sloan Kettering Institute, Asia Technology Center, and more.
Register for free here.
Image credit: Sergey Zolkin
